Amgen (AMGN) Non-Current Debt (2009 - 2026)

Amgen (AMGN) has reported Non-Current Debt for 18 consecutive years, with $51.9 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Debt fell 3.94% year-over-year to $51.9 billion; the TTM figure through Mar 2026 stood at $51.9 billion (down 3.94% YoY), while the FY2025 annual figure was $50.0 billion, down 11.57% from the prior year.
• Non-Current Debt came in at $51.9 billion for Q1 2026 at Amgen, up from $50.0 billion in the prior quarter.
• The five-year high for Non-Current Debt was $63.2 billion in Q4 2023, with the low at $35.7 billion in Q2 2022.
• Average Non-Current Debt over 5 years is $51.8 billion, with a median of $54.0 billion recorded in 2025.
• Across the five-year window, Non-Current Debt jumped 69.11% in 2023 and fell 11.57% in 2025, its largest moves.
• Year by year, Non-Current Debt stood at $37.4 billion in 2022, then surged by 69.11% to $63.2 billion in 2023, then fell by 10.48% to $56.5 billion in 2024, then decreased by 11.57% to $50.0 billion in 2025, then increased by 3.76% to $51.9 billion in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $51.9 billion, $50.0 billion, and $52.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.